Rheumatology

NICE recommends new drug for rheumatoid arthritis

In final guidance, the National Institute for Health and Clinical Excellence (NICE) recommends golimumab (Simponi) as an option for treating rheumatoid arthritis in specific circumstances where previous treatments haven?t worked. Golimumab joins a list of treatment options already recommended by NICE for this condition.
Read more

 http://www.nice.org.uk/newsroom/pressreleases/golimumabforra...

National Institute for Health and Clinical Excellence